As of January 2025, Xvivo Perfusion AB has a market cap of $1.40B. This makes Xvivo Perfusion AB the world's th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $766.43M | -18.06% |
2023 | $935.32M | 80.05% |
2022 | $519.47M | -34.29% |
2021 | $790.55M | -11.31% |
2020 | $891.32M | 84.71% |
2019 | $482.56M | 28.79% |
2018 | $374.70M | 40.43% |
2017 | $266.83M | 6.82% |
2016 | $249.80M | 50.43% |
2015 | $166.06M | 70.55% |
2014 | $97.36M | 2.39% |
2013 | $95.09M | 65.84% |
2012 | $57.34M | - |